<!doctype html public "-//IETF//DTD HTML//EN">
<HTML>
<HEAD>
<TITLE>U</TITLE>
<META NAME="author" CONTENT="Cycle 1">
<META NAME="date" CONTENT="12/20/2007">
</HEAD>
<BODY style="line-height:12pt; font-family:Times New Roman; font-size:10pt; color:#000000" LINK=#004080 VLINK=#004080 ALINK=#004080>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><BR></P>
<P style="margin:0px" align=center><B>U.S. SECURITIES AND EXCHANGE COMMISSION</B></P>
<P style="margin:0px" align=center>Washington, D.C. 20549</P>
<P style="margin:0px" align=center><BR></P>
<P style="line-height:18.667px; margin:0px; font-size:16px" align=center><B>FORM S-8</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933</B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=137.267></TD><TD width=411.867></TD><TD width=137.267></TD></TR>
<TR><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=411.867><P style="line-height:21.333px; margin:0px; font-size:18.667px" align=center><B>DNAPrint Genomics, Inc.</B></P>
</TD><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=411.867><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>(Exact name of registrant as specified in charter)</P>
</TD><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=274.733></TD><TD width=137.267></TD><TD width=274.4></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=top width=274.733><P style="margin:0px" align=center><B>UTAH</B></P>
</TD><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=274.4><P style="margin:0px" align=center><B>59-2780520</B></P>
</TD></TR>
<TR><TD valign=top width=274.733><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>(State or other jurisdiction</P>
<P style="line-height:14.667px; margin:0px; font-size:12px" align=center>of incorporation)</P>
</TD><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=274.4><P style="line-height:13.333px; margin:0px; font-size:12px" align=center>(IRS Employer</P>
<P style="line-height:14.667px; margin:0px; font-size:12px" align=center>Identification No.)</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=137.267></TD><TD width=411.867></TD><TD width=137.267></TD></TR>
<TR><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=411.867><P style="margin:0px" align=center><B>1621 W. University Parkway, Sarasota, FL 34243</B></P>
</TD><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=411.867><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>(Address of principal executive offices)</P>
</TD><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=137.267></TD><TD width=411.867></TD><TD width=137.267></TD></TR>
<TR><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=top width=411.867><P style="margin:0px" align=center><B>Consultant Compensation</B></P>
</TD><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=411.867><P style="line-height:14.667px; margin:0px; font-size:12px" align=center>(Full title of the Plan)</P>
</TD><TD valign=top width=137.267><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=343.2></TD><TD width=343.2></TD></TR>
<TR><TD valign=top width=343.2><P style="margin:0px" align=center><B>Richard Gabriel</B></P>
</TD><TD valign=top width=343.2><P style="margin:0px" align=center><B>With a copy to:</B></P>
</TD></TR>
<TR><TD valign=top width=343.2><P style="margin:0px" align=center><B>Chief Executive Officer and President</B></P>
</TD><TD valign=top width=343.2><P style="margin:0px" align=center><B>Michael T. Cronin</B></P>
</TD></TR>
<TR><TD valign=top width=343.2><P style="margin:0px" align=center><B>DNAPrint Genomics, Inc.</B></P>
</TD><TD valign=top width=343.2><P style="margin:0px" align=center><B>Johnson, Pope, Bokor, Ruppel &amp; Burns, LLP</B></P>
</TD></TR>
<TR><TD valign=top width=343.2><P style="margin:0px" align=center><B>1621 W. University Parkway</B></P>
</TD><TD valign=top width=343.2><P style="margin:0px" align=center><B>911 Chestnut Street</B></P>
</TD></TR>
<TR><TD valign=top width=343.2><P style="margin:0px" align=center><B>Sarasota, FL 34243</B></P>
</TD><TD valign=top width=343.2><P style="margin:0px" align=center><B>Clearwater, FL &nbsp;33756</B></P>
</TD></TR>
<TR><TD valign=top width=343.2><P style="margin:0px" align=center><B>(941) 366-3400</B></P>
</TD><TD valign=top width=343.2><P style="margin:0px" align=center><B>Phone: (727) 461-1818</B></P>
</TD></TR>
<TR><TD valign=top width=343.2><P style="margin:0px" align=center>(Name, address, and telephone number of agent for service)</P>
</TD><TD valign=top width=343.2><P style="margin:0px" align=center><B>Fax: (727)-441-8617</B></P>
</TD></TR>
</TABLE>
<P style="margin:0px" align=center><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><B>CALCULATION OF REGISTRATION FEE</B></P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=227.4></TD><TD width=8.133></TD><TD width=2.667></TD><TD width=5.467></TD><TD width=93.8></TD><TD width=8.867></TD><TD width=2.667></TD><TD width=6.2></TD><TD width=93.8></TD><TD width=8.867></TD><TD width=2.667></TD><TD width=6.2></TD><TD width=93.8></TD><TD width=8.133></TD><TD width=2.667></TD><TD width=5.467></TD><TD width=93.8></TD><TD width=2.333></TD></TR>
<TR><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=227.4><P style="line-height:10.667px; margin:0px; font-size:10.667px" align=center><B>Title&nbsp;of&nbsp;Securities<BR>
to&nbsp;be&nbsp;Registered</B></P>
</TD><TD style="border-top:4px double #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=8.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=2.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=5.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=93.8><P style="line-height:10.667px; margin:0px; font-size:10.667px" align=center><B>Amount&nbsp;to&nbsp;be<BR>
Registered</B></P>
</TD><TD style="border-top:4px double #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=8.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=2.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=6.2><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=93.8><P style="line-height:10.667px; margin:0px; font-size:10.667px" align=center><B>Proposed&nbsp;Maximum<BR>
Offering&nbsp;Price</B></P>
</TD><TD style="border-top:4px double #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=8.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=2.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=6.2><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=93.8><P style="line-height:10.667px; margin:0px; font-size:10.667px" align=center><B>Proposed&nbsp;Aggregate<BR>
Offering&nbsp;Price</B></P>
</TD><TD style="border-top:4px double #000000; border-right:1px solid #000000; border-bottom:1px solid #000000" valign=bottom width=8.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=2.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=5.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-top:4px double #000000; border-bottom:1px solid #000000" valign=bottom width=93.8><P style="line-height:10.667px; margin:0px; font-size:10.667px" align=center><B>Amount&nbsp;of<BR>
Registration&nbsp;Fee</B></P>
</TD><TD valign=bottom width=2.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD style="border-bottom:4px double #000000" valign=top width=227.4><P style="margin:0px; padding-left:13.333px; text-indent:-13.333px">Common Stock</P>
</TD><TD style="border-right:1px solid #000000; border-bottom:4px double #000000" valign=bottom width=8.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=2.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=5.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=93.8><P style="margin:0px" align=center>20,000,000 (1)</P>
</TD><TD style="border-right:1px solid #000000; border-bottom:4px double #000000" valign=bottom width=8.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=2.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=6.2><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=93.8><P style="margin:0px" align=center>$0.0041(2)</P>
</TD><TD style="border-right:1px solid #000000; border-bottom:4px double #000000" valign=bottom width=8.867><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=2.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=6.2><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=93.8><P style="margin:0px" align=center>$82,000</P>
</TD><TD style="border-right:1px solid #000000; border-bottom:4px double #000000" valign=bottom width=8.133><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=2.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=5.467><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:4px double #000000" valign=bottom width=93.8><P style="margin:0px" align=center>$30.70</P>
</TD><TD valign=bottom width=2.333><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="line-height:1.333px; margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:26.867px; text-indent:-26.867px">(1)</P>
<P style="margin:0px; padding-left:26.867px">Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the &#147;Act&#148;), this registration statement shall be deemed to cover additional securities that may be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.</P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:26.867px; text-indent:-26.867px">(2)</P>
<P style="margin:0px; padding-left:26.867px">The price of $0.0041per share, which was the average of the high and low prices of the Registrant&#146;s common stock, as reported on the Over-The-Counter Bulletin Board on December 17, 2007 is set forth solely for purposes of calculating the registration fee pursuant to Rule 457(c) of the Securities Act of 1933, as amended.</P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR>
<BR></P>
<HR style="margin-top:9.6px; margin-bottom:9.6px; color:#004080" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><B>PART I<A NAME="PartI_165959"></A></B></P>
<P style="margin:0px" align=center><B>INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS</B></P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-16px"><B>ITEM 1.</B></P>
<P style="margin:0px; text-indent:48px"><B>PLAN INFORMATION.<A NAME="Item1_PlanInformation__170014"></A></B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px" align=justify>Pursuant to the Note to Part I of the Form S-8, the information required by Part I is not filed with the Securities and Exchange Commission.</P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-16px"><B>ITEM 2.</B></P>
<P style="margin:0px; text-indent:48px"><B>REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION.<A NAME="Item2_RegistrantInformationAndEmp_170017"></A></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>The Registrant will provide without charge to each person to whom a copy of a Section 10(a) Prospectus hereunder is delivered, upon the oral or written request of such person, a copy of any document incorporated in this Registration Statement by reference. Requests for such information should be directed to DNAPrint Genomics, Inc., 1621 W. University Parkway, Sarasota, FL 34243.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=center><B>PART II<A NAME="PartIi_170008"></A></B></P>
<P style="margin:0px" align=center><BR></P>
<P style="margin:0px" align=center><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B></P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-16px"><B>ITEM 3.</B></P>
<P style="margin:0px; text-indent:48px"><B>INCORPORATION OF DOCUMENTS BY REFERENCE.<A NAME="Item3_IncorporationOfDocumentsByR_170033"></A></B></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px">The following are hereby incorporated by reference:</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:72.933px; text-indent:-36.467px" align=justify>(a)</P>
<P style="margin:0px; padding-left:72.933px; text-indent:-0.933px" align=justify>The Registrant&#146;s Annual Report on Form 10-KSB for the fiscal year ended December 31, 2006, filed on March 15, 2007 pursuant to Section 13(c) or 15(d) of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;).</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:72.933px; text-indent:-36.467px" align=justify>(b) </P>
<P style="margin:0px; padding-left:72.933px; text-indent:-0.933px" align=justify>All other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the financial statements contained in the Form 10-KSB referred to in (a) above, which consists of Form 10-QSB filed on May 14, 2007, August 14, 2007 and November 14, 2007.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:72px; text-indent:-36px" align=justify>(c) </P>
<P style="margin:0px; padding-left:72px" align=justify>A description of the securities of the Registrant is contained in a Form SB-2 filed on August 9, 2007, including any amendments or reports filed for the purpose of updating such description.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14, and 15(d) of the Securities Exchange Act of 1934, prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated in this registration statement by reference and to be a part hereof from the date of filing of such documents. Any statement contained in this registration statement, in a supplement to this registration statement or in a document incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained herein or in any subsequently filed supplement to this registration statement or in any document that is subsequently incorporated by reference herein modifies or supersedes such statement. &nbsp;Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.</P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-16px"><B>ITEM 4.</B></P>
<P style="margin:0px; text-indent:48px"><B>DESCRIPTION OF SECURITIES.<A NAME="Item4_DescriptionOfSecurities__170051"></A></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>Not applicable. &nbsp;The class of securities to be offered is registered under Section 12 of the Exchange Act.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-16px" align=justify><B>ITEM 5.</B></P>
<P style="margin:0px; text-indent:48px" align=justify><B>INTEREST OF NAMED EXPERTS AND COUNSEL.<A NAME="Item5_InterestOfNamedExpertsAndCo_170058"></A></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>No named expert or counsel was hired on a contingent basis, will receive a direct or indirect interest in the small business issuer, or was a promoter, underwriter, voting trustee, director, officer, or employee of the Registrant.</P>
<P style="margin:0px" align=justify><BR>
<BR></P>
<P style="margin-top:26.667px; margin-bottom:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<HR style="margin-top:9.6px; margin-bottom:9.6px; color:#004080" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-16px" align=justify><B>ITEM 6.</B></P>
<P style="margin:0px; text-indent:48px" align=justify><B>INDEMNIFICATION OF DIRECTORS AND OFFICERS.<A NAME="Item6_IndemnificationOfDirectorsA_170104"></A></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px">Each person who is or was a director or officer shall be indemnified by us to the full extent permitted or authorized by the General Corporation Law of Utah. Under such law, to the extent that such person is successful on the merits of defense of a suit or proceeding brought against such person by reason of the fact that such person is a director or officer of DNAPrint Genomics, Inc., such person shall be indemnified against expenses, including attorneys' fees, reasonably incurred in connection with such action. If unsuccessful in defense of a third-party civil suit or a criminal suit or if such a suit is settled, such a person shall be indemnified under such law against both (1) expenses (including attorneys' fees) and (2) judgments, fines and amounts paid in settlement if such person acted in good faith and in a manner such person reasonably believed to be in, or not opposed to, our best interests, and with respect to any criminal action, had no reasonable cause to believe such person's conduct was unlawful. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-16px" align=justify><B>ITEM 7.</B></P>
<P style="margin:0px; text-indent:48px" align=justify><B>EXEMPTION FROM REGISTRATION CLAIMED.<A NAME="Item7_ExemptionFromRegistrationCl_170136"></A></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>Not applicable.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-16px" align=justify><B>ITEM 8.</B></P>
<P style="margin:0px; text-indent:48px" align=justify><B>EXHIBITS.<A NAME="Item8_Exhibits__170142"></A></B></P>
<P style="margin:0px" align=justify><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0><TR><TD width=93.4></TD><TD width=22.667></TD><TD width=556.867></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=bottom width=93.4><P style="line-height:10.667px; margin:0px"><B>Exhibit No.</B></P>
</TD><TD valign=bottom width=22.667><P style="font-size:2pt">&nbsp;</P></TD><TD style="border-bottom:1px solid #000000" valign=bottom width=556.867><P style="line-height:10.667px; margin:0px"><B>Description</B></P>
</TD></TR>
<TR><TD valign=top width=93.4><P style="margin:0px">5.1</P>
</TD><TD valign=top width=22.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=556.867><P style="margin:0px">Opinion of Michael T. Cronin, Esq. (filed herewith).</P>
</TD></TR>
<TR><TD valign=top width=93.4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=22.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=556.867><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=93.4><P style="margin:0px">10.1</P>
</TD><TD valign=top width=22.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=556.867><P style="margin:0px">Letter Agreement between the Company and Arthur Sytkowski, dated March 1, 2007(included as exhibit 10.56 to the Form 10-KSB filed March 15, 2007, and incorporated herein by reference).</P>
</TD></TR>
<TR><TD valign=top width=93.4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=22.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=556.867><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=93.4><P style="margin:0px">10.2</P>
</TD><TD valign=top width=22.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=556.867><P style="margin:0px">&nbsp;Agreement between the Company and Dr. Arthur Sytkowski, dated August 1, 2007 (included as exhibit 10.1 to the Form 10-QSB filed November 14, 2007, and incorporated herein by reference).</P>
</TD></TR>
<TR><TD valign=top width=93.4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=22.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=556.867><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=93.4><P style="margin:0px">23.1</P>
</TD><TD valign=top width=22.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=556.867><P style="margin:0px">Consent of Counsel (included in Exhibit 5.1 hereto).</P>
</TD></TR>
<TR><TD valign=top width=93.4><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=22.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=556.867><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=93.4><P style="margin:0px">23.2</P>
</TD><TD valign=top width=22.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=556.867><P style="margin:0px">Consent of Independent Registered Certified Public Accountants &nbsp;(filed herewith).</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:-16px" align=justify><B>ITEM 9.</B></P>
<P style="margin:0px; text-indent:48px" align=justify><B>UNDERTAKINGS.<A NAME="Item9_Undertakings__170259"></A></B></P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:36.467px; text-indent:-36.467px" align=justify>(a)</P>
<P style="margin:0px; padding-left:36.467px; text-indent:-0.467px" align=justify>The Registrant hereby undertakes:</P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:96px; text-indent:-36.467px" align=justify>1.</P>
<P style="margin:0px; padding-left:96px" align=justify>To file, during any period in which it offers or sells securities are being made, a post-effective amendment to this registration statement to:</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:132px; text-indent:-36.467px" align=justify>(i) </P>
<P style="margin:0px; padding-left:132px" align=justify>Include any additional or changed material information with respect to the plan of distribution.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:96px; text-indent:-36.467px" align=justify>2.</P>
<P style="margin:0px; padding-left:96px" align=justify>For determining liability under the Securities Act of 1933, that each post-effective amendment as a new registration statement of the securities offered, and the offering of the securities at that time to be the initial bona fide offering.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:-16px; padding-left:96px; text-indent:-36.467px" align=justify>3.</P>
<P style="margin:0px; padding-left:96px" align=justify>File a post-effective amendment to remove from registration any of the securities that remain unsold at the end of the offering.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin:0px" align=justify>For determining any liability under the Securities Act, treat the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in form of prospectus filed by the Registrant under Rule 424(b)(1), or (4) or 497(h) under the Securities Act as part of this registration statement as of the time the Commission declared it effective.</P>
<P style="margin:0px" align=justify><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px" align=justify>For determining any liability under the Securities Act, treat each post-effective amendment that contains a form of prospectus as a new registration statement for the securities offered in the registration statement, and that offering of the securities at that time as the initial bona fide offering of those securities.</P>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><BR>
<BR></P>
<P style="margin-top:26.667px; margin-bottom:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
<HR style="margin-top:9.6px; margin-bottom:9.6px; color:#004080" noshade size=1.333>
<P style="margin:0px; page-break-before:always" align=center><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px" align=center><B>SIGNATURES<A NAME="Signatures_170710"></A></B></P>
<P style="margin-top:0px; margin-bottom:13.333px; text-indent:26.667px">Pursuant to the requirements of the Securities Act of 1933, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Sarasota, State of Florida, on December 21, 2007.</P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=178.533></TD><TD width=83.667></TD><TD width=38.533></TD><TD width=207.667></TD><TD width=178></TD></TR>
<TR><TD valign=top width=178.533><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=83.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=38.533><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=385.667 colspan=2><P style="margin:0px"><B>DNAPrint Genomics, Inc.</B></P>
</TD></TR>
<TR><TD valign=top width=178.533><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=83.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=38.533><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=385.667 colspan=2><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=178.533><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=83.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=38.533><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=207.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=178><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=178.533><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=83.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=38.533><P style="margin:0px" align=right>By:</P>
</TD><TD style="border-bottom:1px solid #000000" valign=top width=207.667><P style="margin:0px">/s/ Richard Gabriel</P>
</TD><TD valign=top width=178><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=178.533><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=83.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=38.533><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=207.667><P style="margin:0px">Richard Gabriel</P>
</TD><TD valign=top width=178><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=178.533><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=83.667><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=38.533><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=385.667 colspan=2><P style="margin:0px">Chief Executive Officer, President and Director</P>
</TD></TR>
</TABLE>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px; text-indent:26.667px">Pursuant to the requirements of the Securities Act of 1933. &nbsp;This registration statement has been signed by the following persons in the capacities and on the date indicated.</P>
<P style="margin:0px"><BR></P>
<TABLE style="font-size:13.333px" cellspacing=0 align=center><TR><TD width=267.067></TD><TD width=287.133></TD><TD width=118.733></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=top width=267.067><P style="margin:0px">/s/ Tony Frudakis</P>
</TD><TD valign=top width=287.133><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=118.733><P style="margin:0px">December 21, 2007</P>
</TD></TR>
<TR><TD valign=top width=267.067><P style="margin:0px">Tony Frudakis</P>
</TD><TD valign=top width=287.133><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=118.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=267.067><P style="margin:0px">Director</P>
</TD><TD valign=top width=287.133><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=118.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=267.067><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=287.133><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=118.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD style="border-bottom:1px solid #000000" valign=top width=267.067><P style="margin:0px">/s/ Hector Gomez</P>
</TD><TD valign=top width=287.133><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=118.733><P style="margin:0px">December 21, 2007</P>
</TD></TR>
<TR><TD valign=top width=267.067><P style="margin:0px">Hector Gomez</P>
</TD><TD valign=top width=287.133><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=118.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=267.067><P style="margin:0px">Director</P>
</TD><TD valign=top width=287.133><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=118.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
<TR><TD valign=top width=267.067><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=287.133><P style="font-size:2pt">&nbsp;</P></TD><TD valign=top width=118.733><P style="font-size:2pt">&nbsp;</P></TD></TR>
</TABLE>
<P style="line-height:1.333px; margin-top:0px; margin-bottom:1.333px"><BR></P>
<P style="margin-top:0px; margin-bottom:13.333px"><BR></P>
<P style="margin:0px"><BR></P>
<P style="margin:0px"><BR>
<BR></P>
<P style="margin-top:26.667px; margin-bottom:0px" align=center><BR></P>
<P style="margin:0px"><BR></P>
</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "s8.htm", "secsgml_size_bytes": 33033}]
{"company-data": {"conformed-name": "DNAPRINT GENOMICS INC", "cik": "0001127354", "assigned-sic": "8731", "irs-number": "592780520", "state-of-incorporation": "UT", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-148306", "film-number": "071324177"}, "business-address": {"street1": "1621 W. UNIVERSITY PARKWAY", "city": "SARASOTA", "state": "FL", "zip": "34243", "phone": "9413663400"}, "mail-address": {"street1": "1621 W. UNIVERSITY PARKWAY", "street2": "NO SUITE", "city": "SARASOTA", "state": "FL", "zip": "34243"}}
U
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
DNAPrint Genomics, Inc.
(Exact name of registrant as specified in charter)
UTAH
59-2780520
(State or other jurisdiction
of incorporation)
(IRS Employer
Identification No.)
1621 W. University Parkway, Sarasota, FL 34243
(Address of principal executive offices)
Consultant Compensation
(Full title of the Plan)
Richard Gabriel
With a copy to:
Chief Executive Officer and President
Michael T. Cronin
DNAPrint Genomics, Inc.
Johnson, Pope, Bokor, Ruppel & Burns, LLP
1621 W. University Parkway
911 Chestnut Street
Sarasota, FL 34243
Clearwater, FL  33756
(941) 366-3400
Phone: (727) 461-1818
(Name, address, and telephone number of agent for service)
Fax: (727)-441-8617
CALCULATION OF REGISTRATION FEE
Title of Securities
to be Registered
Amount to be
Registered
Proposed Maximum
Offering Price
Proposed Aggregate
Offering Price
Amount of
Registration Fee
Common Stock
20,000,000 (1)
$0.0041(2)
$82,000
$30.70
(1)
Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the "Act"), this registration statement shall be deemed to cover additional securities that may be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
(2)
The price of $0.0041per share, which was the average of the high and low prices of the Registrant's common stock, as reported on the Over-The-Counter Bulletin Board on December 17, 2007 is set forth solely for purposes of calculating the registration fee pursuant to Rule 457(c) of the Securities Act of 1933, as amended.
PART I
INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS
ITEM 1.
PLAN INFORMATION.
Pursuant to the Note to Part I of the Form S-8, the information required by Part I is not filed with the Securities and Exchange Commission.
ITEM 2.
REGISTRANT INFORMATION AND EMPLOYEE PLAN ANNUAL INFORMATION.
The Registrant will provide without charge to each person to whom a copy of a Section 10(a) Prospectus hereunder is delivered, upon the oral or written request of such person, a copy of any document incorporated in this Registration Statement by reference. Requests for such information should be directed to DNAPrint Genomics, Inc., 1621 W. University Parkway, Sarasota, FL 34243.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
ITEM 3.
INCORPORATION OF DOCUMENTS BY REFERENCE.
The following are hereby incorporated by reference:
(a)
The Registrant's Annual Report on Form 10-KSB for the fiscal year ended December 31, 2006, filed on March 15, 2007 pursuant to Section 13(c) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act").
(b)
All other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the financial statements contained in the Form 10-KSB referred to in (a) above, which consists of Form 10-QSB filed on May 14, 2007, August 14, 2007 and November 14, 2007.
(c)
A description of the securities of the Registrant is contained in a Form SB-2 filed on August 9, 2007, including any amendments or reports filed for the purpose of updating such description.
All documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14, and 15(d) of the Securities Exchange Act of 1934, prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold shall be deemed to be incorporated in this registration statement by reference and to be a part hereof from the date of filing of such documents. Any statement contained in this registration statement, in a supplement to this registration statement or in a document incorporated by reference herein, shall be deemed to be modified or superseded for purposes of this registration statement to the extent that a statement contained herein or in any subsequently filed supplement to this registration statement or in any document that is subsequently incorporated by reference herein modifies or supersedes such statement.  Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration statement.
ITEM 4.
DESCRIPTION OF SECURITIES.
Not applicable.  The class of securities to be offered is registered under Section 12 of the Exchange Act.
ITEM 5.
INTEREST OF NAMED EXPERTS AND COUNSEL.
No named expert or counsel was hired on a contingent basis, will receive a direct or indirect interest in the small business issuer, or was a promoter, underwriter, voting trustee, director, officer, or employee of the Registrant.
ITEM 6.
INDEMNIFICATION OF DIRECTORS AND OFFICERS.
Each person who is or was a director or officer shall be indemnified by us to the full extent permitted or authorized by the General Corporation Law of Utah. Under such law, to the extent that such person is successful on the merits of defense of a suit or proceeding brought against such person by reason of the fact that such person is a director or officer of DNAPrint Genomics, Inc., such person shall be indemnified against expenses, including attorneys' fees, reasonably incurred in connection with such action. If unsuccessful in defense of a third-party civil suit or a criminal suit or if such a suit is settled, such a person shall be indemnified under such law against both (1) expenses (including attorneys' fees) and (2) judgments, fines and amounts paid in settlement if such person acted in good faith and in a manner such person reasonably believed to be in, or not opposed to, our best interests, and with respect to any criminal action, had no reasonable cause to believe such person's conduct was unlawful. Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable.
ITEM 7.
EXEMPTION FROM REGISTRATION CLAIMED.
Not applicable.
ITEM 8.
EXHIBITS.
Exhibit No.
Description
5.1
Opinion of Michael T. Cronin, Esq. (filed herewith).
10.1
Letter Agreement between the Company and Arthur Sytkowski, dated March 1, 2007(included as exhibit 10.56 to the Form 10-KSB filed March 15, 2007, and incorporated herein by reference).
10.2
Agreement between the Company and Dr. Arthur Sytkowski, dated August 1, 2007 (included as exhibit 10.1 to the Form 10-QSB filed November 14, 2007, and incorporated herein by reference).
23.1
Consent of Counsel (included in Exhibit 5.1 hereto).
23.2
Consent of Independent Registered Certified Public Accountants  (filed herewith).
ITEM 9.
UNDERTAKINGS.
(a)
The Registrant hereby undertakes:
1.
To file, during any period in which it offers or sells securities are being made, a post-effective amendment to this registration statement to:
(i)
Include any additional or changed material information with respect to the plan of distribution.
2.
For determining liability under the Securities Act of 1933, that each post-effective amendment as a new registration statement of the securities offered, and the offering of the securities at that time to be the initial bona fide offering.
3.
File a post-effective amendment to remove from registration any of the securities that remain unsold at the end of the offering.
For determining any liability under the Securities Act, treat the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in form of prospectus filed by the Registrant under Rule 424(b)(1), or (4) or 497(h) under the Securities Act as part of this registration statement as of the time the Commission declared it effective.
For determining any liability under the Securities Act, treat each post-effective amendment that contains a form of prospectus as a new registration statement for the securities offered in the registration statement, and that offering of the securities at that time as the initial bona fide offering of those securities.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Sarasota, State of Florida, on December 21, 2007.
DNAPrint Genomics, Inc.
By:
/s/ Richard Gabriel
Richard Gabriel
Chief Executive Officer, President and Director
Pursuant to the requirements of the Securities Act of 1933.  This registration statement has been signed by the following persons in the capacities and on the date indicated.
/s/ Tony Frudakis
December 21, 2007
Tony Frudakis
Director
/s/ Hector Gomez
December 21, 2007
Hector Gomez
Director